Literature DB >> 28806256

Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer.

Eugene J Teoh1, Maria T Tsakok, Kevin M Bradley, Katherine Hyde, Manil Subesinghe, Fergus V Gleeson.   

Abstract

A 66-year-old man presented with biochemical recurrence of prostate cancer and underwent F-fluciclovine PET/CT to detect sites of recurrence. He had a history of resected truncal stage IIIC malignant melanoma, with bilateral axillary node involvement on sentinel node biopsy, in complete remission for 3 years. F-fluciclovine PET/CT demonstrated an incidental fluciclovine-avid right axillary node (SUVmax = 4.3). Diagnostic sampling confirmed recurrent malignant melanoma.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28806256     DOI： 10.1097/RLU.0000000000001789

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  4 in total

Review 1.  Amino Acid Metabolism as a Target for Breast Cancer Imaging.

Authors:  Gary A Ulaner; David M Schuster
Journal:  PET Clin       Date:  2018-07

Review 2.  Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy.

Authors:  Evelien A J van Genugten; Jetty A M Weijers; Sandra Heskamp; Manfred Kneilling; Michel M van den Heuvel; Berber Piet; Johan Bussink; Lizza E L Hendriks; Erik H J G Aarntzen
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

3.  Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity.

Authors:  Zuzana Balážová; Igor Černý; Petr Vyškovský
Journal:  Case Rep Oncol       Date:  2020-04-21

4.  18F-Fluciclovine-Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination.

Authors:  Franklin C Wong; Lucia Martiniova; Avantika Masrani; Gregory C Ravizzini
Journal:  Clin Nucl Med       Date:  2022-02-01       Impact factor: 7.794
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.